Innovative Liver Elasticity, Attenuation, and Dispersion Ultrasound Study
NCT ID: NCT04012242
Last Updated: 2022-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
400 participants
OBSERVATIONAL
2019-06-15
2022-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The EUS ShearWave Elastography Liver Fibrosis Study
NCT04115046
Endoscopic Ultrasound Shear Wave Elastography Study
NCT06592820
Comparative Diagnostic Yield of Contrast-Enhanced Versus Conventional Ultrasound Guidance for Coaxial Biopsy of Hepatic Lesions
NCT07249268
Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions
NCT01908166
Tissue Elastography Assessement and Cuteous and Cubcutaneous Thickness Measurement Following Manual Lymph Drainage in Legs With Lymphedema
NCT05186142
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NAFLD patients who are scheduled for liver biopsy
Ultrasound application
Shear wave elastography, shear wave dispersion, attenuation imaging, and intensity analysis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasound application
Shear wave elastography, shear wave dispersion, attenuation imaging, and intensity analysis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Without a history of alcohol use, which lead to alcoholic hepatic involvement (pure alcohol below 30 g/day for male, 20 g/day for female).
Exclusion Criteria
* Hepatitis B, Hepatitis C and HIV patients
* Primary biliary cholangitis, Primary sclerosing cholangitis, and Autoimmune hepatitis patients
* Wilson's disease, α1-antitrypsin deficiency, and hemochromatosis patients
* Malignant liver tumor, common bile duct stone, and jaundice patients
* Patients after jejunoileal bypass surgery or massive intestinal resection surgery
* Patients whose treatment changes during the period between imaging examination and liver biopsy, including medications such as antidiabetic drugs and other treatments which may change the fat deposition or inflammation of liver.
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tokyo Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Katsutoshi Sugimoto
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Katsutoshi Sugimoto, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Tokyo Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Southern California
Los Angeles, California, United States
Rocky Vista University
Parker, Colorado, United States
Northwestern University
Evanston, Illinois, United States
The Surgical Hospital at Southwoods
Boardman, Ohio, United States
University of Washington
Seattle, Washington, United States
SunYatSen University First Hospital
Guangzhou, , China
SunYatSen University Third Hospital
Guangzhou, , China
Zhejiang University No. 2 Hospital
Hangzhou, , China
University Paris Nord
Paris, , France
University of Erlangen
Erlangen, , Germany
University of Leipzig
Leipzig, , Germany
University of Pavia
Pavia, , Italy
Policlinico Umberto I, Univ. La Sapienza
Rome, , Italy
Hyogo Medical University
Hyōgo, , Japan
Kurume University
Kurume, , Japan
Chung-Ang University Hospital
Seoul, , South Korea
Seoul National University Hospital
Seoul, , South Korea
Charing Cross Hospital / Imperial College London
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Edward GRANT
Role: primary
Jing GAO
Role: primary
Thomas GRANT
Role: primary
Richard BARR
Role: primary
Ted DUBINSKY
Role: primary
Xiaoyan XIE
Role: primary
Rongqin ZHENG
Role: primary
Pintong HUANG
Role: primary
Valerie VILGRAIN
Role: primary
Deike STROBEL
Role: primary
Thomas KARLAS
Role: primary
Giovanna FERRAIOLI
Role: primary
Vito CANTISANI
Role: primary
Hiroko Iijima, MD, PhD
Role: primary
Hirohisa Yano, MD, PhD
Role: primary
Byung Ihn CHOI
Role: primary
Jae Young LEE
Role: primary
Adrian LIM
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Sugimoto K, Moriyasu F, Dioguardi Burgio M, Vilgrain V, Jesper D, Strobel D, Blank V, Karlas T, Grant EG, Kelahan LC, Gabriel H, Choi BI, Nishimura T, Iijima H, Dubinsky TJ, Gao J, Lee DH, Lee JY, Zhao Y, Huang P, Zeng J, Lim A, Xie X, Barr RG, Cantisani V, Ferraioli G, Sakamaki K, Itoi T, Kage M, Yano H. US Markers and Necroinflammation, Steatosis, and Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease: The iLEAD Study. Radiology. 2024 Aug;312(2):e233377. doi: 10.1148/radiol.233377.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TokyoMU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.